hATTR is progressive and physical function deteriorates rapidly(1)

Disease progression

hATTR is progressive and physical function deteriorates rapidly(1)

hATTR is progressive and physical function deteriorates rapidly¹

Monteiro C, Mesgazardeh JS et al. Predictive model of response to tafamidis in hereditary ATTR polyneuropathy. JCI Insight. 2019 Jun 20;4(12):e126526
Adams D. Ther Adv Neurol Disord. 2013;6(2):129–139.
Coutinho P et al, Forty years of experience with type I amyloid neuropathy. Review of 483 cases. In: Glenner G, Costa P, de Freitas A (Editors), Amyloid and amyloidosis. Amsterdam: Excerpta Medica; 1980. p. 88–98. * Due to early onset (<50 years) Val30met
Berk J et al. Impact of Hereditary Transthyretin-Mediated Amyloidosis on Daily Living and Work Productivity: Baseline Results from APOLLO. Presented at the 16th International Symposium on Amyloidosis (ISA), March 26–29, 2018, Kumamoto, Japan.
Adams D, Ando Y et al., J Neurol. 2021 Jun;268(6):2109-212.
Gertz MA. Hereditary ATTR amyloidosis: burden of illness and diagnostic challenges. Am J Manag Care. 2017;23(suppl 7):S107–S112.
Amyloidosis Foundation. Understanding the patient voice in hereditary transthyretin-mediated amyloidosis (ATTR amyloidosis). Available at: https://www.amyloidosissupport.org/support_groups/fam_isabell_attr.pdf. Accessed April 2020.